BayBio Notes
<< < 1 2 3 4 5 10 20 100 > >>
- KineMed and CHDI Foundation Collaborate to Develop New Biomarkers of Disease Progression and to Evaluate Potential Therapeutics for Huntington’s Disease - May 14, 2012
EMERYVILLE, Calif. & NEW YORK--(BUSINESS WIRE)--CHDI/KineMed collaboration to use unique dynamic proteomics technology to evaluate treatments for Huntington's Disease
Read More... - Xconomy Editor Luke Timmerman a Finalist for Loeb Award - May 14, 2012
Read More... - Medgenics Announces First Quarter 2012 Financial Results - May 14, 2012
MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of a novel technology for the sustained production and...
Read More... - Are People with HIV/AIDS More Prone to Sudden Cardiac Death? - May 14, 2012
What is the connection, if any, between sudden cardiac death and people with HIV/AIDS? And can that knowledge help prolong their lives?<div class="feedflare"> <a...
Read More... - Maxygen to Receive $30 Million Payment from Bayer - May 14, 2012
SAN MATEO, Calif.--(BUSINESS WIRE)--Maxygen, Inc. (Nasdaq:MAXY), a biopharmaceutical company, today announced that it will receive a $30.0 million payment from Bayer HealthCare LLC in connection...
Read More... - Cellerant Announces Publication Demonstrating Significant Survival Benefits and Preclinical Proof of Concept With Myeloid Progenitors as Radiation Countermeasure - May 14, 2012
SAN CARLOS, Calif.--(BUSINESS WIRE)--Cellerant Therapeutics, Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and...
Read More... - HyStem®-C Demonstrated Effective when Formulated with Human Heart Cells and Transplanted in an Animal Model of Heart Disease - May 14, 2012
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) announced today the publication of a scientific paper demonstrating the effectiveness of HyStem®-C in the transplantation of heart...
Read More... - Preventing Depression Requires Proactive Interventions by Health Care System - May 14, 2012
Major depressive episodes can be prevented, and to help ensure that they are, the health care system should provide routine access to depression-prevention interventions, just as patients receive...
Read More... - Results from Two Studies Demonstrate the Clinical Utility of CardioDx Gene Expression Test in Patients with Suspected Obstructive Coronary Artery Disease - May 14, 2012
PALO ALTO, Calif.--(BUSINESS WIRE)--CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced results of two studies evaluating the role of the Corus® CAD gene...
Read More... - ASCO Preview: Eight Cancer Drugs to Watch at the Big Show - May 14, 2012
Read More... - FDA panel backs Gilead's four drugs-in-one HIV tablet - May 11, 2012
<img src='http://assets.bizjournals.com/sanfrancisco/blog/biotech/gilead-logo*100.jpeg?v=1'>An HIV therapy from Gilead Sciences Inc. that combines four drugs, including a new...
Read More... - FDA Advisory Committee Supports Approval of Gilead’s Once-Daily Quad Single Tablet Regimen for HIV - May 11, 2012
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted 13 to...
Read More... - OncoMed files for $115 million IPO - May 11, 2012
<img src='http://assets.bizjournals.com/sanfrancisco/blog/biotech/hastings,paulTEASEJune2010*100.jpg?v=1'>OncoMed Pharmaceuticals Inc. is seeking $115 million in an initial public...
Read More... - Social Security: Fixing the Glaring Gap for Women - May 11, 2012
After a lifetime of lower wages and time out of the labor market for caregiving, women typically receive less from Social Security than men, with millions of widows and women of color falling into...
Read More... - Pharmacy School Remembers Harry W. Hind - May 11, 2012
Harry W. Hind, a 1939 graduate of the UCSF School of Pharmacy who invented solutions that revolutionized contact lens use, as well as a topical patch to treat pain from shingles, died on April 12....
Read More... - UCSF School of Pharmacy Celebrates 2012 Commencement - May 11, 2012
Dean Mary Anne Koda-Kimble, PharmD, congratulated the graduates of the nation's top-ranked pharmacy school while faculty, friends and family members looked on at the 2012 commencement ceremony...
Read More... - Aradigm Announces First Quarter 2012 Financial Results - May 11, 2012
HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation announces first quarter 2012 financial results.
Read More... - FDA Advisory Committee Supports Approval of Gilead’s Truvada® for Reducing the Risk of Acquiring HIV - May 11, 2012
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted to...
Read More... - FDA panel recommendation sets Gilead's Truvada on course to be first HIV preventative - May 10, 2012
<img src='http://assets.bizjournals.com/sanfrancisco/blog/biotech/Truvada*100.JPG?v=1'>Gilead Sciences Inc.'s HIV treatment Truvada is safe and effective as a way to prevent...
Read More... - Exelixis Announces May 17th Webcast of Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference - May 10, 2012
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) announced today that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will present at...
Read More...
